Clinical Trials in New York State

Showing 6341-6360 of 17,167 trials

A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.

NCT03515811

The objectives of this prospective, two-arm, multicenter post-market study is to confirm safety and performance through the incidence of subjects reporting serious adverse device effects (ADEs) up to and including 30 days following use of Signia™ Stapling System with Endo GIA™ with Tri-Staple™ Technology and Tri-Staple™ 2.0 Intelligent Reloads in subjects undergoing indicated abdominal or thoracic procedures for resection, transection and creation of anastomosis per the IFU.

Abdominal InjuryThoracic Diseases

Medtronic - MITG136 participantsStarted Jan 2019

Los Angeles, California, United States • Albany, New York, United States • Cary, North Carolina, United States +8 more locations

COMPLETEDPhase 379 miles

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

NCT02507687

This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

Glaucoma, Open-AngleOcular Hypertension

AbbVie240 participantsStarted Aug 2015

Dothan, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +92 more locations

A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Find Trials by Condition in New York State

Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

PARTNER 3 Trial - Aortic Valve-in-Valve

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

A Study of TAK-071 in People With Parkinson Disease

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

Comparative Performance of a Vaginal Yeast Test

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial